Creative Medical Technology Holdings, Inc. (CELZ) Earnings History
Annual and quarterly earnings data from 2006 to 2025
Loading earnings history...
CELZ EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
CELZ Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 63.4% | -100324.8% | -99916.8% |
| 2024 | 60.0% | -52216.9% | -49940.7% |
| 2023 | 60.0% | -62445.9% | -58739.7% |
| 2022 | 67.8% | -11562.5% | -11449.3% |
| 2021 | 45.4% | -3562.2% | 21892.8% |
Download Data
Export CELZ earnings history in CSV or JSON format
Free sign-in required to download data
Creative Medical Technology Holdings, Inc. (CELZ) Earnings Overview
As of May 8, 2026, Creative Medical Technology Holdings, Inc. (CELZ) reported trailing twelve-month net income of -$6M, reflecting +32.1% year-over-year growth. The company earned $-2.31 per diluted share over the past four quarters, with a net profit margin of -99916.8%.
Looking at the long-term picture, CELZ's historical earnings data spans multiple years. The company achieved its highest annual net income of $19M in fiscal 2021.
Creative Medical Technology Holdings, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including MESO (-$102M net income, -593.9% margin), NKTR (-$164M net income, -297.1% margin), RCEL (-$49M net income, -67.8% margin), CELZ has room to improve margins relative to the peer group. Compare CELZ vs MESO →
CELZ Earnings vs Peers
Earnings metrics vs comparable public companies
CELZ Historical Earnings Data (2006–2025)
20 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$6M | -9.1% | -$6M | $-2.52 | -99916.8% | -100324.8% |
| 2024 | -$5M | -3.9% | -$6M | $-3.71 | -49940.7% | -52216.9% |
| 2023 | -$5M | +47.9% | -$6M | $-3.76 | -58739.7% | -62445.9% |
| 2022 | -$10M | -152.8% | -$10M | $-9.28 | -11449.3% | -11562.5% |
| 2021 | $19M | +152.9% | -$3M | $56.10 | 21892.8% | -3562.2% |
| 2020 | -$36M | -328.2% | -$1M | $-626.88 | -22082.2% | -677.7% |
| 2019 | -$8M | +37.9% | -$1M | $-5017.67 | -5126.1% | -682.9% |
| 2018 | -$14M | -413.5% | -$1M | $-11351.33 | -10977.2% | -895.7% |
| 2017 | -$3M | -247.1% | -$1M | $-17379.79 | -55398.1% | -24537.6% |
| 2016 | $-766,072 | -2390.4% | $-766,072 | $-5471.94 | - | - |
See CELZ's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CELZ Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CELZ vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCELZ — Frequently Asked Questions
Quick answers to the most common questions about buying CELZ stock.
Is CELZ growing earnings?
CELZ EPS is $-2.31, with earnings growth accelerating to +32.1%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-6M.
What are CELZ's profit margins?
Creative Medical Technology Holdings, Inc. net margin is -99916.8%, with operating margin at -100324.8%. Below-average margins reflect competitive or cost pressures.
How consistent are CELZ's earnings?
CELZ earnings data spans 2006-2025. The accelerating earnings trend is +32.1% YoY. Historical data enables comparison across business cycles.